Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (TSXV: $N.V) (TSXV: $KHRN.V) (TSX: $APHA.TO) (NYSE: $APHA)
Delta, Kelowna, BC, January 14, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/01141FAF-N-KHRN-APHA.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as insights
from thought leaders and experts.
In
today’s we look at a few early announcements.
But
first, Purpose Investments Inc. launched the Medical Cannabis & Wellness UCITS ETF,
representing Purpose’s first offering in the European market. The Fund is being
made available through Purpose’s partnership with HANetf, an independent
European ETF specialist backed by renowned investor Steve Cohen’s Point72
Ventures.
The first of its kind for European investors, the Fund
listed earlier today on the Deutsche Boerse XETRA exchange in Germany. It will
be listed on the London Stock Exchange in the UK and the Borsa Italiana in
Italy later this month.
“The medical cannabis industry was pioneered in Canada,
and we’re thrilled with the opportunity to partner with HANetf to take what we
have learned from our Purpose Marijuana Opportunities Fund (MJJ) to Europe. We
believe that the cannabis sector is still in the infancy stages of a multi-year
growth phase and that there is ample opportunity for innovation and new
discoveries. We are very excited to embark on this journey with HANetf in a
global investor market,” said Som Seif, CEO and founder of Purpose Investments.
The Fund offers European investors unique exposure to
the global medical cannabis market and the CBD wellness sector. Additionally,
the Fund invests in ancillary services that support companies within the
medical cannabis and CBD categories.
“Up until now, European investors have experienced
restricted access to the cannabis market. With the launch of this truly
innovative ETF, there is now a product for investors who want exposure to the
cannabis industry through a pre-screened basket of Cannabis securities and in a
regulated UCITS ETF. Due to the operational and legal due diligence that has
gone into developing this truly innovative ETF, investors can readily access an
investment vehicle which can significantly reduce their legal risk versus
investing directly in single cannabis securities. It is also is a great way to
diversify as investors don’t need to research each individual security and the
ETF may help to withstand the short-term volatility of individual securities,
potentially making for a lower risk, longer-term investment,” said Hector
McNeil, co-Founder and co-CEO of HANetf.
For more information on the Fund, please visit: https://www.hanetf.com/product/6/fund/the-medical-cannabis-and-wellness-ucits-etf-acc
Fire
& Flower Holdings Corp. (TSX:
FAF)
and its wholly-owned subsidiary Fire & Flower Inc., announced that it
has achieved the milestone of 45 open and operating cannabis retail stores.
Fire & Flower
has previously stated that the Company anticipated achieving the milestone of
45 retail cannabis stores by the end of its fiscal year, being February 1,
2020. The Company has achieved this milestone several weeks in advance of its
previously stated goal and today has 46 open and operating stores across its
retail network.
The new stores
included in the Company's milestone achievement are located at the following
addresses:
●
1108 4th street SW, Calgary, Alberta
●
6004 Country Hills Blvd NE, Calgary,
Alberta
●
212, 11245 Valley Ridge Drive NW, Calgary,
Alberta
●
350, 590 Baseline Road, Sherwood Park,
Alberta
●
19-99 Wye Road, Sherwood Park, Alberta
●
1276 3 Avenue South, Lethbridge, Alberta
●
10 Westwind Drive, Spruce Grove, Alberta
●
40 Hewlett Park Landing, Sylvan Lake,
Alberta
●
4331-52 Avenue, Whitecourt, Alberta
"Fire &
Flower is committed to delivering on the targets that we have provided to our
shareholders and reaching 45 cannabis retail stores several weeks in advance of
when we had anticipated to reach this target is a clear demonstration of our
discipline in achieving our goals," shared Trevor Fencott, Fire &
Flower's Chief Executive Officer. "Achieving this aggressive goal is a
testament to our deep retail experience and strong management team. As the
cannabis industry continues to face headwinds, Fire & Flower is well positioned
to continue to achieve growth and demonstrate leadership in the category."
The Company
continues to focus on opening new retail stores across Alberta, where the AGLC
continues to issue retail licences, and in the province of Ontario where open
licensing has commenced. Fire & Flower is also closely monitoring
regulatory environments and taking proactive steps in provinces across Canada
to ensure early market entry when private retail opportunities emerge.
Namaste
Technologies Inc. (TSXV:
N)
(OTC:
NXTTF), a leading online platform for cannabis products,
accessories, and responsible education today announced that Choklat Inc., an
Alberta-based craft chocolate manufacturer and chocolatier in which Namaste
holds a 49% equity position, has
received a processing license from Health Canada
to produce a line of chocolate bars, drink mixes and infused sugar.
"Receiving
the processing license from Health Canada is a significant achievement and
milestone," said Brad Churchill, CEO of Choklat. "We look forward to
introducing our cannabis infused product line, products with a pure chocolatey
taste with no aftertaste, across Canada leveraging the extensive B2B sales
channels that CannMart Inc. has built. Our high-quality cannabis infused bars
and beverages will be based on our own chocolate recipe made from a special
cocoa bean sourced from the jungles of South America. This is an exciting time
for Choklat, CannMart and Namaste as we enter the competitive cannabis 2.0
landscape."
"Brad
Churchill is a true pioneer when it comes to the actual production of
chocolate, and he is now applying his extensive experience and passion to
produce high quality cannabis-infused chocolates," said Meni Morim, Chief
Executive Officer at Namaste Technologies Inc. "We believe there is pent
up demand for cannabis-infused edible products on a national scale. Choklat is
one of the first food processors in Canada to receive its processing license
from Health Canada and we expect their products to be on shelves in March, allowing
for the Health Canada notice period. We invested in Choklat not only to
maximize the significant market opportunity for cannabis-infused edibles but
also because we see Brad as a true craftsman in his trade and the quality of
his products speak for themselves."
The
Cannabis Regulations require licenced
processors to submit a notification to Health Canada of their intent to sell
each novel cannabis product in Canada at least 60 calendar days before making
such cannabis products available for sale. CannMart will be submitting up to 11
unique product SKUs to Health Canada for the new derivative product formats
that the Company intends to offer for sale beginning in March. New products are
expected to include dark, white and milk chocolate bars, chocolate-based
beverages and infused sugar, that have been formulated, developed and packaged
to meet the regulatory requirements set out by Health Canada. These new product
formats will be added to Namaste's e-commerce website CannMart.com and offered
through provincial cannabis stores in authorized markets.
What
sets Choklat apart from other chocolatiers is that Choklat imports premium
cocoa beans in the world, then roasts, grinds and refines them on-site into
chocolate that meets exacting taste specifications. Creating the chocolate
allows for complete control over the quality and taste of the final products
which Namaste and Choklat believe provides an advantage over competitors.
Namaste, CannMart and Choklat are all about treating customers with respect and
integrity and using only the highest quality products and natural ingredients.
Choklat
has existing sales of non-infused products through both its online e-commerce
site and a network of distributors across Canada. The chocolate manufacturer
has experienced significant expansion while preparing for the legalization of
edibles and has non-infused products available in over 150 retail outlets
across Canada, including an increasing number of Safeway and Sobeys stores in
Western Canada. Choklat has also applied for and received its FDA number for
the sale of non-infused chocolate bars
in the United States.
Khiron
Life Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF), a vertically integrated cannabis leader with core
operations in Latin America,announced the
opening of Zerenia, a fully integrated medical care clinic designed to meet
patient health and well-being. Operating in a 15,000 sq. ft facility in
Bogota's prime medical services district, the clinic increases Khiron's
clinical capacity by 75% and forms part of the Company's patient acquisition
strategy as it prepares for the issue of cannabis prescription in Colombia.
Zerenia offers a
person-centered integrated care model, with the concept of integrative medicine
combining traditional and complementary medicine, and with evidence-based
treatments and high professional practices. Services are delivered across
multiple clinical units include: Pain management, mental health, surgical,
neurology and dentistry, supported by rehabilitation, complementary medicine
and diagnostic technology, involving programs for managing multiple symptoms in
different pathologies. Prominently located in Bogota's city centre, Zerenia
builds on the integration and growth of the Company's wholly-owned Ilans
neurological clinics and its over 60 physicians, and is staffed by a team of
health professionals and clinical leaders representing different specialties.
Phase one of the
15,000 sq. ft clinic is open for treatments and phase two will be ready to
receive patients in March 2020.
"We are
excited to be opening Zerenia in Bogota, a busy city of more than 10 million
people and a population increasingly demanding convenient, one-stop access to
medical care of the highest professional standards. In a state of the art
clinic, our physicians and health care professionals will consult with patients
and offer appropriate treatment therapies." Comments Martha Edith Oyuela, Khiron Health
Vice President. "For the first time patients will have access to an array
of integrated professional, patient-centred options."
"Our strategy
in launching Zerenia is to meet a very clear market need to treat the whole
patient in one professional environment. With the success of our Ilans clinics,
and the growing movement towards integrated medical care, we are leading the
market in bringing this concept to Colombia. This strategy further expands our
reach to bring patients into the Khiron network, including those that are well
suited for cannabis therapies." Adds Khiron CEO and Director Alvaro
Torres.
Aphria Inc. (TSX:
APHA) (NYSE:
APHA) reported its
results for the second quarter ended November 30, 2019. All amounts are
expressed in thousands of Canadian dollars, unless otherwise noted and except
for per gram, kilogram, kilogram equivalents, and per share amounts. The
Company also announced that Irwin D. Simon, will officially remove
"interim" from his title, effective today. In addition to his
responsibilities as Aphria's Chairman of the Board, Mr. Simon had been serving
as Interim Chief Executive Officer since February 2019.
"We
are very pleased with our strong growth and execution in Canada demonstrated by
our increase in adult-use cannabis revenue and positive adjusted EBITDA as a
result of our compelling brands and market positioning," stated Irwin D.
Simon, Chairman and Chief Executive Officer. "We are continuing to expand
our capabilities internationally with solid progress during the quarter in
Germany and South America and look to monetize non-core assets. We are
confident in our market position and our ability to generate sustainable profit
growth. I am honoured to continue to work closely with our tremendous team
around the world to fuel growth and value for all of our stakeholders. Going
forward, we believe our brands, cultivation expertise, cash position and
balance sheet will continue to differentiate us in the cannabis industry, and
we remain focused on the highest return opportunities for growth."
Some
of the key Operating Highlights included, a revenue for adult-use cannabis of
$29.0 million in the second quarter, an increase of 46% from prior quarter, a
net cannabis revenue of $33.7 million in the second quarter, an increase of 9%
from prior quarter and a net revenue of $120.6 million in the second quarter,
an increase of 457% from prior year quarter and decrease of 4% from prior quarter.
Aphria
was also recognized for seven awards at the 6th Annual Canadian
Cannabis Awards with all five of Aphria's medical and recreational brands
receiving awards, as well as Broken Coast's Master Grower, Kevin Anderson,
winning 'Master Grower' accolades and Aphria's Solei's CBN Renew oil
'Innovation of the Year'.
Carl Merton,
Aphria's Chief Financial Officer commented, "We are updating our annual
outlook with a little over four months left in our fiscal year to reflect
certain market dynamics that have evolved relative to our initial
expectations. We look forward to
generating an acceleration in our revenue and profit growth in the second half
of the fiscal year and continue to believe the Canadian and international
cannabis industry outlook remains robust. Aphria is well positioned for
long-term sustainable growth as we continue to manage the controllable aspects
of our business."
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
